Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.
Purity:
97.90%
CAS Number:
[1638935-72-4]
Target:
Others|||TNF
T9901A-006
* VAT and and shipping costs not included. Errors and price changes excepted